Jasper Therapeutics, Inc. <JSPR.O>: Piper Sandler initiates coverage with overweight rating; target price $2
JSPR•Related News
North Sea Crude-Vitol buys WTI Midland
XLE•
PGIM names Robert Scheer head of Direct Lending for DACH region
PRU•
Oil prices rise to six-week highs on worsening Middle East conflict
XLE•
UAE says its energy exports will not be 'held hostage' by Iran war
XLE•
US imports more Congo copper as consumer acceptance grows
XLB•